Approach to Fibromyalgia and the Role of Phytotherapy in Treatment

被引:0
作者
Akcakaya, Adem [1 ]
机构
[1] Univ Hlth Sci, Fac Med, Dept Pathol, Istanbul, Turkiye
来源
BEZMIALEM SCIENCE | 2024年 / 12卷 / 02期
关键词
Fibromyalgia; phytotherapy; pharmacological treatments; non-pharmacological treatments; etiopathogenesis; CHRONIC-FATIGUE-SYNDROME; CENTRAL SENSITIZATION; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; FORMALIN TEST; PAIN; SYMPTOMS; PREVALENCE; EXTRACT; SLEEP;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibromyalgia (FM) is characterized by chronic widespread pain accompanied by fatigue, poor sleep quality, and numerous accompanying conditions. Its prevalence worldwide is around 2.7%, and it is more common in women. Although its epidemiology and pathophysiology cannot be precisely explained, it is known that various factors coexist. Over the years, guidelines containing various criteria have been established for the diagnosis of the disease. The goal of treatment in FM is to improve the patient's quality of life and minimize symptoms as much as possible. The success of treatment in FM is limited. Many patients seek alternative treatment methods, including diet and lifestyle changes. Recently, medical nutritional therapies and phytotherapy products have been at the forefront of research in this area. Phytotherapy products can be added alone or in combination with other treatment methods and can enhance the success of treatment. In this article, the epidemiology, pathophysiology, diagnostic methods, pharmacological and non -pharmacological methods used in the treatment of FM syndrome will be discussed, and the most widely used phytotherapeutic products will be addressed.
引用
收藏
页码:266 / 278
页数:13
相关论文
共 106 条
[61]   Chronic widespread pain and its comorbidities - A population-based study [J].
Kato, Kenji ;
Sullivan, Patrick F. ;
Evengard, Birgitta ;
Pedersen, Nancy L. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) :1649-1654
[62]   The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia [J].
Katz, RS ;
Heard, AR ;
Mills, M ;
Leavitt, F .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2004, 10 (02) :53-58
[63]   Diagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity [J].
Kilicarslan, Aysegul ;
Yurdakul, Fatma Gul ;
Bodur, Hatice .
TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2018, 64 (02) :133-139
[64]  
문현일, 2010, [Journal of Life Science, 생명과학회지], V20, P496
[65]   Applying the ACR Preliminary Diagnostic Criteria in the Diagnosis and Assessment of Fibromyalgia [J].
Kim, So Mi ;
Lee, Sang Heon ;
Kim, Hae Rim .
KOREAN JOURNAL OF PAIN, 2012, 25 (03) :173-182
[66]   Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity [J].
Latremoliere, Alban ;
Woolf, Clifford J. .
JOURNAL OF PAIN, 2009, 10 (09) :895-926
[67]  
Leroux Andrew, 2021, Digit Biomark, V5, P89, DOI 10.1159/000515576
[68]   An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome [J].
Lister, RE .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (02) :195-199
[69]   Neurogenic inflammation in fibromyalgia [J].
Littlejohn, Geoffrey ;
Guymer, Emma .
SEMINARS IN IMMUNOPATHOLOGY, 2018, 40 (03) :291-300
[70]   Modulation of NMDA Receptor Activity in Fibromyalgia [J].
Littlejohn, Geoffrey ;
Guymer, Emma .
BIOMEDICINES, 2017, 5 (02)